Novartis AGNVS

$147.08-3.80 (-2.52%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$282B
Mega-cap
+75%
2016 — today
10-Year Price
+118%
2016 — today
52-Week Range
$113.50$168.62
Current $147.08· 61%

Novartis AG, based in Basel, Switzerland, discovers, develops, and distributes medical products globally through two primary divisions. Innovative Medicines provides prescription drugs across therapeutic areas including ophthalmology, neuroscience, immunology, cardiovascular, and metabolic diseases. Sandoz manufactures and commercializes generic drugs, anti-infectives, biosimilars, and active pharmaceutical ingredients. The firm maintains strategic alliances, including collaborations with Alnylam and Kura Oncology.

Valuation in context

P/E ratio
21.1
Above average
Pricier than usual over the last 10 years
P/B ratio
7.2
Near historic high
Near historic highs — last 10 years
EV / EBITDA
14.4
Historically pricey
Historically pricey — last 10 years
Dividend Yield
3.2%
Historically low
Historically low relative to the last 10 years
PEG ratio
1.4
Below average
Below the 10-year average
FCF Yield
5.8%
Below average
Below the 10-year average
Free · No credit card needed

Get alerted when NVS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.